Download Free Sample Report

The global Biotechnology & Pharmaceutical Services Outsourcing market was valued at US$ 61100 million in 2023 and is projected to reach US$ 93570 million by 2030, at a CAGR of 6.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

When it comes to pharmaceutical research and development however, success is never guaranteed. The average cost of drug development can reach into the billions of dollars, and it takes an average of 10 years to bring a new drug to market. In addition, many drugs fail to be clinical effective and subsequently never see the light of day.

Due to these risks, pharmaceutical companies are not always eager to utilize their onsite resources for drug R&D. Certain cost-saving measures implemented in the pharmaceutical space have included outsourcing these activities, helping organizations reduce both their operational and manufacturing costs, thereby lowering financial risk.
This report aims to provide a comprehensive presentation of the global market for Biotechnology & Pharmaceutical Services Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnology & Pharmaceutical Services Outsourcing. This report contains market size and forecasts of Biotechnology & Pharmaceutical Services Outsourcing in global, including the following market information:

• Global Biotechnology & Pharmaceutical Services Outsourcing Market Revenue, 2018-2023, 2024-2030, ($ millions)
• Global top five companies in 2023 (%)

North America held more than 50.0% share for the pharmaceutical/biotechnology services outsourcing market in 2015. The presence of several multinational and local consulting firms in this region contributed towards the growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period. Low cost of manufacturing and availability of qualified labor is likely to foster contract manufacturing in this region. Moreover, economic policy reforms in countries such as India and China are anticipated to create open and balanced economy, which presents ample opportunity for market players to invest in this region.
We surveyed the Biotechnology & Pharmaceutical Services Outsourcing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biotechnology & Pharmaceutical Services Outsourcing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Biotechnology & Pharmaceutical Services Outsourcing Market Segment Percentages, by Type, 2023 (%)

• Consulting
• Auditing & Assessment
• Regulatory Affairs
• Product Maintenance
• Product Design & Development
• Product Testing & Validation
• Training & Education
• Others

• Regenerative Medicine
• Biobanking
• Drug Discovery

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

• Key companies Biotechnology & Pharmaceutical Services Outsourcing revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Biotechnology & Pharmaceutical Services Outsourcing revenues share in global market, 2023 (%)

• Quantic Group
• QuintilesIMS
• Parexel International Corporation
• Lachman Associates
• GMP Pharmaceuticals
• Management Forum
• Quality Context
• Inspired Pharma
• Concept Heidelberg GmbH
• RSSL

Outline of Major Chapters:
Chapter 1: Introduces the definition of Biotechnology & Pharmaceutical Services Outsourcing, market overview.
Chapter 2: Global Biotechnology & Pharmaceutical Services Outsourcing market size in revenue.
Chapter 3: Detailed analysis of Biotechnology & Pharmaceutical Services Outsourcing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biotechnology & Pharmaceutical Services Outsourcing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.